Dalrada Financial Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
DFCO Over the counter 3841 https://dalrada.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Dalrada Financial Corporation

Watson Rx Solutions Earns Two Prestigious Pharmaceutical Accreditations from URAC - May 22nd, 2023 1:30 pm
Dalrada Financial Corporation Reports Revenue of $9.5 Million, an Increase of over $4 Million or 80% During Q3 2023 - May 16th, 2023 1:30 pm
Dalrada Corporation Streamlines Board of Directors to Reflect US and Global Expansion - May 11th, 2023 1:30 pm
Dalrada Energy Services Signs Agreement with AKF Group for Clean Energy Efficiency Building Projects with an Estimated Value of More than $10 Million Annually - Apr 25th, 2023 1:30 pm
Dalrada Corporation Appoints Brian Murphy to its Clean Energy Advisory Board - Apr 14th, 2023 12:00 pm
Genefic’s Watson Rx Solutions Earns Prestigious NABP Merchant Accreditation - Apr 13th, 2023 12:00 pm
Genefic Announces Opening of New Corporate Headquarters in Northern San Diego County - Mar 7th, 2023 1:00 pm
Dalrada’s Strong Revenue Generation Includes 23% Growth to $5.3 Million During the Second Quarter of Fiscal 2023 - Feb 15th, 2023 2:30 pm
Dalrada Technology Ltd. Moves into New UK Headquarters Designated for Clean Energy Technology and Manufacturing - Feb 9th, 2023 1:00 pm
Six Leaders Named to Genefic Board of Directors - Jan 24th, 2023 1:00 pm
Dalrada Appoints Harvey Hershkowitz as Chairman and CEO of Genefic - Jan 17th, 2023 1:00 pm
Dalrada Health Unveils New Operating Structure to Support Significant Growth, Changes Name to Genefic - Jan 12th, 2023 1:00 pm
Dalrada Selects New Independent Auditor to Support Current Business Growth - Dec 22nd, 2022 1:00 pm
Dalrada Health’s Empower Genomics Receives CDC Approval and Funding for Vaccine Initiative - Dec 7th, 2022 1:00 pm
Dalrada Reports Continued Growth with $4.3 Million Revenue During First Quarter 2023 - Nov 29th, 2022 1:00 pm
Dalrada Reports Fiscal 2022 Results, Continues Strong Upward Trajectory in All Four Core Segments - Nov 1st, 2022 12:00 pm
University of Arkansas Contracts Dalrada Corporation’s Deposition Technology Ltd. to Build a Plasma Enhanced Chemical Vapor Deposition Tool - Oct 31st, 2022 5:52 pm
Dalrada Corporation Acquires Bothof Brothers Construction - Oct 24th, 2022 11:22 pm
Dalrada Corporation Announces Delay in Annual Report on Form 10-K - Oct 18th, 2022 10:53 pm
Dalrada Corporation Partners with Averett University to Drive Campus-Wide Green Energy Initiatives - Sep 27th, 2022 5:18 pm